Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

USA - NYSE:NYT - US6501111073 - Common Stock

58.48 USD
0 (0%)
Last: 9/18/2025, 7:00:00 PM
59.0287 USD
+0.55 (+0.94%)
After Hours: 9/18/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to NYT. NYT was compared to 99 industry peers in the Media industry. NYT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NYT has a correct valuation and a medium growth rate. These ratings would make NYT suitable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year NYT was profitable.
In the past year NYT had a positive cash flow from operations.
NYT had positive earnings in each of the past 5 years.
In the past 5 years NYT always reported a positive cash flow from operatings.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

With an excellent Return On Assets value of 11.42%, NYT belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
With an excellent Return On Equity value of 16.55%, NYT belongs to the best of the industry, outperforming 85.86% of the companies in the same industry.
NYT has a better Return On Invested Capital (14.36%) than 94.95% of its industry peers.
NYT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is above the industry average of 8.87%.
The 3 year average ROIC (11.43%) for NYT is below the current ROIC(14.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROIC 14.36%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NYT has a Profit Margin of 11.92%. This is amongst the best in the industry. NYT outperforms 82.83% of its industry peers.
NYT's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 15.50%, NYT belongs to the best of the industry, outperforming 80.81% of the companies in the same industry.
NYT's Operating Margin has improved in the last couple of years.
NYT has a Gross Margin (50.04%) which is comparable to the rest of the industry.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NYT is still creating some value.
Compared to 1 year ago, NYT has less shares outstanding
NYT has less shares outstanding than it did 5 years ago.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

NYT has an Altman-Z score of 9.34. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
NYT has a better Altman-Z score (9.34) than 90.91% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.34
ROIC/WACC1.65
WACC8.7%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

NYT has a Current Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NYT (1.48) is better than 61.62% of its industry peers.
NYT has a Quick Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
NYT has a better Quick ratio (1.48) than 62.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.40% over the past year.
The Earnings Per Share has been growing by 16.92% on average over the past years. This is quite good.
NYT shows a small growth in Revenue. In the last year, the Revenue has grown by 7.82%.
The Revenue has been growing slightly by 7.37% on average over the past years.
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%

3.2 Future

The Earnings Per Share is expected to grow by 13.13% on average over the next years. This is quite good.
NYT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.49% yearly.
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

NYT is valuated quite expensively with a Price/Earnings ratio of 26.11.
NYT's Price/Earnings ratio is a bit cheaper when compared to the industry. NYT is cheaper than 65.66% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, NYT is valued at the same level.
With a Price/Forward Earnings ratio of 22.95, NYT is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as NYT.
When comparing the Price/Forward Earnings ratio of NYT to the average of the S&P500 Index (22.88), we can say NYT is valued inline with the index average.
Industry RankSector Rank
PE 26.11
Fwd PE 22.95
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NYT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NYT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 20.92
EV/EBITDA 17.24
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

NYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
NYT's earnings are expected to grow with 12.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)1.54
EPS Next 2Y12.58%
EPS Next 3Y12.09%

More info and screens

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.23%.
Compared to an average industry Dividend Yield of 4.58, NYT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

On average, the dividend of NYT grows each year by 21.48%, which is quite nice.
NYT has paid a dividend for at least 10 years, which is a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

NYT pays out 29.50% of its income as dividend. This is a sustainable payout ratio.
The dividend of NYT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP29.5%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

More info and screens

NEW YORK TIMES CO-A

NYSE:NYT (9/18/2025, 7:00:00 PM)

After market: 59.0287 +0.55 (+0.94%)

58.48

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners97.12%
Inst Owner Change-0.29%
Ins Owners0.62%
Ins Owner Change-0.15%
Market Cap9.52B
Analysts75
Price Target58.59 (0.19%)
Short Float %6.48%
Short Ratio5.55
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP29.5%
Div Incr Years6
Div Non Decr Years11
Ex-Date07-09 2025-07-09 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.94%
Min EPS beat(2)15.73%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)12.21%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)19.88%
EPS beat(12)12
Avg EPS beat(12)28.39%
EPS beat(16)16
Avg EPS beat(16)25.56%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)2.58%
PT rev (3m)0.57%
EPS NQ rev (1m)1.53%
EPS NQ rev (3m)9.21%
EPS NY rev (1m)5.89%
EPS NY rev (3m)6.02%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 26.11
Fwd PE 22.95
P/S 3.54
P/FCF 20.92
P/OCF 19.43
P/B 4.92
P/tB 7.42
EV/EBITDA 17.24
EPS(TTM)2.24
EY3.83%
EPS(NY)2.55
Fwd EY4.36%
FCF(TTM)2.8
FCFY4.78%
OCF(TTM)3.01
OCFY5.15%
SpS16.51
BVpS11.89
TBVpS7.88
PEG (NY)1.55
PEG (5Y)1.54
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROCE 18.71%
ROIC 14.36%
ROICexc 18.96%
ROICexgc 30.93%
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
FCFM 16.93%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.07%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 97.77%
Profit Quality 142.1%
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 9.34
F-Score9
WACC8.7%
ROIC/WACC1.65
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%
EBIT growth 1Y22.62%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year31.33%
EBIT Next 3Y16.76%
EBIT Next 5YN/A
FCF growth 1Y101.81%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y92.64%
OCF growth 3Y15.12%
OCF growth 5Y16.67%